Expression of marker CD54 was increased (P < 0.001) and higher percentage (P < 0.01) of CD54+ neutrophils was observed in CLL patients compared to healthy controls (Table 1, Figure 1, Supplementary Figure 2 in the on-line Supplement). Here, ICAM1 is linked to B-cell chronic lymphocytic leukemia.